Kalvista Pharmaceuticals Inc (KALV)
Operating Income Growth
79.08%
Quarterly · Period ending:
KALV Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported79.08%period ending
Latest reported79.08%period ending
KALV Quarterly Operating Income YoY % (-251.47% → 79.08%)
Year-over-year change
High-resolution chart · PNG
KALV operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 79.0814% | |
| 45.4075% | |
| -0.5217% | |
| -33.4592% | |
| -13.5693% | |
| -29.5285% | |
| -54.0073% | |
| -51.9781% | |
| -52.72% | |
| -23.0321% | |
| -14.9249% | |
| -10.5525% | |
| -18.3395% | |
| -0.9819% | |
| -9.6598% | |
| -34.8432% | |
| -48.6033% | |
| -110.8161% | |
| -84.6726% | |
| -35.1243% | |
| -101.429% | |
| 0.5266% | |
| -37.5929% | |
| -51.0142% | |
| 20.4529% | |
| -91.0511% | |
| -89.8426% | |
| -36.4531% | |
| -279.2523% | |
| -53.2444% | |
| 17.5846% | |
| -28.5348% | |
| 41.6241% | |
| 46.4581% | |
| -146.8607% | |
| -126.736% | |
| 22.0895% | |
| -45.7533% | |
| 50.9083% | |
| 57.5613% | |
| -33.1973% | |
| -45.8999% | |
| -37.3038% | |
| -132.6355% | |
| -164.0625% | |
| -251.4733% |